<!DOCTYPE html><!--[if lt IE 9]>
<html class='lt-ie9 no-js' lang='en'>
<![endif]-->
<!--[if gte IE 9]><!-->
<html class='no-js' lang='en'>
  <!--<![endif]-->
  <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
    <title>Entyvio HCP Engagement - Quiz | Question 5 Answer</title>
    <meta name="description" content="Media Literacy Council">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link rel="icon" type="image/png" href="/entyvio_hcp/favicon.ico">
    <link rel="stylesheet" href="/entyvio_hcp/assets/styles/main.css">
  </head>
  <body class="page-quiz/question-3/answer"><!--[if lt IE 9]>
<p class='browsehappy'>You are using an <strong>outdated</strong> browser. Please <a href='http://browsehappy.com/'>upgrade your browser</a> to improve your experience.</p>
<![endif]-->
    <header>
      <div class="header">
        <div class="header-wrap">
          <div class="container">
            <div class="logo-wrap hidden"><img class="svg" src="/entyvio_hcp/assets/images/entyvio_logo.svg"></div>
            <div class="navigation-wrap">
              <div class="nav-wrap">
                <div class="nav-mobile mobile-only">
                  <div class="nav-menu">
                    <div class="hamburger-menu">
                      <div class="nav-line l1"></div>
                      <div class="nav-line l2"></div>
                      <div class="nav-line l3"></div>
                    </div>
                  </div>
                </div>
                <nav class="nav-links">
                  <div class="nav-links__wrap">
                    <ul class="links not-patient-home">
                      <li class="links-item" data-menu="menu-1"><a class="button btn hallow menu-1"
                          style="min-width:undefined" href="/entyvio_hcp/patient-cases" target="_self"
                          aria-label="Patient cases">
                          <div class="button-wrap"><span class="btn__text">Patient cases</span></div>
                        </a></li>
                      <li class="links-item" data-menu="menu-2"><a class="button btn hallow menu-2"
                          style="min-width:undefined" href="/entyvio_hcp/quiz/question-1/question" target="_self"
                          aria-label="Quiz">
                          <div class="button-wrap"><span class="btn__text">Quiz</span></div>
                        </a></li>
                    </ul>
                  </div>
                </nav>
              </div>
              <div class="home-wrap"><a class="button btn hallow home-btn" style="min-width:undefined"
                  href="/entyvio_hcp/area-selection" target="_self" aria-label="Home">
                  <div class="button-wrap"><i class="icon icon-home"></i><span class="btn__text"></span></div>
                </a></div>
            </div>
          </div>
        </div>
        <div class="menu-overlay"></div>
      </div>
    </header>
    <main>
      <div class="site-wrapper">
        <section class="arrows">
          <div class="arrows-wrap">
            <div class="arrow arrow-prev" data-url="/entyvio_hcp/quiz/question-5/question"><a
                href="/entyvio_hcp/quiz/question-5/question" target="_self"><svg class="arrow--btn" id="arrow-prev--svg"
                  data-name="Layer 2" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"
                  viewBox="0 0 30 45">
                  <defs>
                    <style>
                      .cls-1--prev {
                        fill: url(#linear-gradient--prev);
                        filter: drop-shadow(0px 0px 2px rgba(255, 255, 255, .5));
                        transition: all .2s linear;
                      }
                      .cls-1--prev,
                      .cls-2--prev {
                        stroke-width: 0px;
                      }
                      .cls-2--prev {
                        fill: none;
                      }
                      .cls-3--prev {
                        clip-path: url(#clippath);
                      }
                      .arrow--btn:hover .cls-1--prev {
                        fill: url(#linear-gradient--prev-rev);
                        filter: drop-shadow(0px 0px 3px rgba(255, 65, 45, 1));
                        stroke-width: 3px;
                      }
                    </style>
                    <clippath id="clippath">
                      <rect class="cls-2--prev" width="30" height="45"></rect>
                    </clippath>
                    <lineargradient id="linear-gradient--prev" x1="-2557.7" y1="11205.86" x2="-2519.9" y2="11205.86"
                      gradientTransform="translate(11194.15 2675.96) rotate(90.59)" gradientUnits="userSpaceOnUse">
                      <stop offset="0" stop-color="#872580"></stop>
                      <stop offset=".19" stop-color="#9b2c6a"></stop>
                      <stop offset=".52" stop-color="#b9374b"></stop>
                      <stop offset=".81" stop-color="#cb3e37"></stop>
                      <stop offset="1" stop-color="#d24131"></stop>
                    </lineargradient>
                    <lineargradient id="linear-gradient--prev-rev" x1="11276.25" y1="2672.81" x2="11314.05" y2="2672.81"
                      gradienttransform="translate(2799.98 -11248.36) rotate(90.59)" gradientunits="userSpaceOnUse">
                      <stop offset="0" stop-color="#d24131"></stop>
                      <stop offset=".19" stop-color="#cb3e37"></stop>
                      <stop offset=".48" stop-color="#b9374b"></stop>
                      <stop offset=".81" stop-color="#9b2c6a"></stop>
                      <stop offset="1" stop-color="#872580"></stop>
                    </lineargradient>
                  </defs>
                  <g id="Layer_1-2" data-name="Layer 1">
                    <g class="cls-3--prev">
                      <path class="cls-1--prev"
                        d="m3.41,22.28c0-.51.23-1,.62-1.33L23.64,4.03c.75-.64,1.87-.56,2.52.19.65.75.56,1.87-.19,2.52L7.89,22.33l17.76,15.96c.73.66.79,1.79.13,2.52-.66.73-1.79.79-2.52.13L4,23.63c-.38-.34-.6-.83-.59-1.34Z">
                      </path>
                    </g>
                  </g>
                </svg></a></div>
            <div class="arrow arrow-next" data-url="/entyvio_hcp/quiz/end"><a class="btnNextQuestion"
                href="/entyvio_hcp/quiz/end" target="_self"><svg class="arrow--btn" id="arrow-next--svg"
                  data-name="Layer 2" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"
                  viewBox="0 0 30 45">
                  <defs>
                    <style>
                      .cls-1--next {
                        fill: url(#linear-gradient--next);
                        filter: drop-shadow(0px 0px 2px rgba(255, 255, 255, .5));
                        transition: all .2s linear;
                      }
                      .cls-1--next,
                      .cls-2--next {
                        stroke-width: 0px;
                      }
                      .cls-2--next {
                        fill: none;
                      }
                      .cls-3--next {
                        clip-path: url(#clippath);
                      }
                      .arrow--btn:hover .cls-1--next {
                        fill: url(#linear-gradient--next-rev);
                        filter: drop-shadow(0px 0px 3px rgba(255, 65, 45, 1));
                        stroke-width: 3px;
                      }
                    </style>
                    <clippath id="clippath">
                      <rect class="cls-2--next" width="30" height="45"></rect>
                    </clippath>
                    <lineargradient id="linear-gradient--next" x1="11288.13" y1="2757.79" x2="11325.94" y2="2757.79"
                      gradientTransform="translate(-2858.49 11300.77) rotate(-89.41)" gradientUnits="userSpaceOnUse">
                      <stop offset="0" stop-color="#d24131"></stop>
                      <stop offset=".19" stop-color="#cb3e37"></stop>
                      <stop offset=".48" stop-color="#b9374b"></stop>
                      <stop offset=".81" stop-color="#9b2c6a"></stop>
                      <stop offset="1" stop-color="#872580"></stop>
                    </lineargradient>
                    <lineargradient id="linear-gradient--next-rev" x1="-2551.88" y1="11090.92" x2="-2514.08"
                      y2="11090.92" gradientTransform="translate(-11052.69 -2627.56) rotate(-89.41)"
                      gradientUnits="userSpaceOnUse">
                      <stop offset="0" stop-color="#872580"></stop>
                      <stop offset=".19" stop-color="#9b2c6a"></stop>
                      <stop offset=".52" stop-color="#b9374b"></stop>
                      <stop offset=".81" stop-color="#cb3e37"></stop>
                      <stop offset="1" stop-color="#d24131"></stop>
                    </lineargradient>
                  </defs>
                  <g id="Layer_1-2" data-name="Layer 1">
                    <g class="cls-3--next">
                      <path class="cls-1--next"
                        d="m26.59,22.72c0,.51-.23,1-.62,1.33L6.36,40.97c-.75.64-1.87.56-2.52-.19-.65-.75-.56-1.87.19-2.52l18.08-15.59L4.35,6.71c-.73-.66-.79-1.79-.13-2.52.66-.73,1.79-.79,2.52-.13l19.27,17.32c.38.34.6.83.59,1.34Z">
                      </path>
                    </g>
                  </g>
                </svg></a></div>
          </div>
        </section>
        <div id="pageQuestion" data-question="5"></div>
        <section
          class="main-content quiz-question-list quiz quiz-radio-mb-small quiz-question-5 quiz-question-list--answers">
          <div class="container container-main">
            <div class="section-header">
              <div class="flex items-start"><img class="hidden mr-3 mt-4" id="answerCheck"
                  src="/entyvio_hcp/assets/images/quiz/check-mark.svg" width="40">
                <h1>All answers are correct.</h1>
              </div>
            </div>
            <div class="section-main">
              <div class="questionnaire-wrap question-list-wrap">
                <div class="question-text"></div>
                <div class="question-choices  lettered question-choices--tablet-sm" id="questionChoices"
                  data-question="" data-next-page="undefined">
                  <div class="custom-radio" data-group="question-1" data-index="1">
                    <div class="trivia-wrap"></div>
                    <div class="radio-wrap"><label for="question-1_01">
                        <p>In some real-world studies about biologics in IBD, propensity-score-adjusted analysis is used
                          as a tool to control for confounding bias, creating two groups that have comparable
                          distributions of baseline characteristics.<sup>1,2</sup></p>
                      </label>
                      <div class="increment-letter">A</div>
                    </div>
                  </div>
                  <div class="custom-radio" data-group="question-1" data-index="2">
                    <div class="trivia-wrap"></div>
                    <div class="radio-wrap"><label for="question-1_11">
                        <p>VEDO<sub>IBD</sub> was a prospective, head-to-head, real-world study that compared the
                          effectiveness of vedolizumab and anti-TNF therapy in biologic-naïve patients with
                          CD.<sup>2</sup></p>
                      </label>
                      <div class="increment-letter">B</div>
                    </div>
                  </div>
                  <div class="custom-radio" data-group="question-1" data-index="3">
                    <div class="trivia-wrap"></div>
                    <div class="radio-wrap"><label for="question-1_21">
                        <p>In the VEDO<sub>IBD</sub> study, clinical remission rate after 2 years was significantly
                          higher in the vedolizumab group than in the anti-TNF group (74.2% vs 44.7%; P < 0.05) in
                            biologic-naïve patients with CD.<sup>2</sup></p>
                      </label>
                      <div class="increment-letter">C</div>
                    </div>
                  </div>
                  <div class="custom-radio" data-group="question-1" data-index="4">
                    <div class="trivia-wrap"></div>
                    <div class="radio-wrap"><label for="question-1_31">
                        <p>In the cohort of the VEDO<sub>IBD</sub> study, there was no significant difference in the
                          distribution of disease locations as a baseline characteristic of patients with CD in the
                          anti-TNF group and the vedolizumab group.<sup>2</sup></p>
                      </label>
                      <div class="increment-letter">D</div>
                    </div>
                  </div>
                  <div class="custom-radio" data-group="question-1" data-index="5">
                    <div class="trivia-wrap"></div>
                    <div class="radio-wrap"><label for="question-1_41">
                        <p>In the EVOLVE Expansion study, which was a multicenter, observational, retrospective cohort
                          study, vedolizumab-treated patients with CD showed higher cumulative rates of mucosal healing
                          than those treated with ustekinumab over 36 months.<sup>3</sup>
                        <ul class="list list-inside mt-2 pl-4">
                          <li><small>In the EVOLVE Expansion study, cumulative rates of mucosal healing were 91.3% in
                              the vedolizumab-treated group and 87.4% in the ustekinumab-treated group over 36 months (P
                              = 0.02).<sup>3</sup></small></li>
                        </ul>
                        </p>
                      </label>
                      <div class="increment-letter">E</div>
                    </div>
                  </div>
                </div>
                <div class="px-4">
                  <div class="explore-box explore-box--bottom">
                    <div class="explore-title">Click the buttons to explore…</div>
                    <div class="explore-buttons">
                      <div class="explore-btn-wrap" data-name="vedo_study_design"><button
                          class="button btn hallow explore--btn btn-line-height-initial" style="min-width:undefined"
                          type="button" aria-label="VEDO<sub>IBD</sub> study design">
                          <div class="button-wrap"><span class="btn__text">VEDO<sub>IBD</sub> study design</span></div>
                        </button></div>
                      <div class="explore-btn-wrap" data-name="evolve_expansion"><button
                          class="button btn hallow explore--btn btn-line-height-initial" style="min-width:undefined"
                          type="button" aria-label="EVOLVE Expansion<br>study design">
                          <div class="button-wrap"><span class="btn__text">EVOLVE Expansion<br>study design</span></div>
                        </button></div>
                    </div>
                  </div>
                </div>
                <div class="question-trivia hidden">
                  <div class="timeline-data" data-timeline="vedo_study_design">
                    <div class="scrollable-modal">
                      <div class="column-wrap mb-6">
                        <div class="column-section">
                          <div class="title font-bold text-xl">VEDO<sub>IBD</sub>: study design</div>
                          <p class="text-purple-entyvio-1 text-sm">This study was an observational, RWE, mITT study
                            based on prospectively collected data from the VEDO<sub>IBD</sub> registry</p>
                        </div>
                      </div>
                      <div class="column-wrap mb-6">
                        <div class="column-section"><img class="mx-auto"
                            src="/entyvio_hcp/assets/images/quiz/vedo-study-design-graphic-1.svg" width="800"
                            height="201"></div>
                      </div>
                      <div class="column-wrap mb-6">
                        <div class="column-section">
                          <div class="flex flex-col items-start gap-5 md_flex-row"><img class="mr-4"
                              src="/entyvio_hcp/assets/images/quiz/flag-round-germany.png" width="42" height="40">
                            <div class="text-sm text-black">This RWE study enrolled patients who were included in the
                              VEDO<sub>IBD</sub> registry from 45 IBD-experienced centers across Germany.</div>
                          </div>
                        </div>
                      </div>
                      <div class="column-wrap mb-6">
                        <div class="column-section">
                          <p class="text-sm text-black">The study aimed to compare the effectiveness of vedolizumab
                            versus anti-TNF in biologic-naïve patients with CD.</p>
                          <p class="text-sm text-black">Switchers of a drug were considered as treatment failures in the
                            mITT analysis, whereas switchers were excluded in the per protocol analysis. To reduce
                            selection bias in the estimation of treatment effects, the IPTW PS was implemented.</p>
                          <p class="text-sm text-gray-500">Limitations: This study was not a randomized controlled
                            clinical study. Some of the results suggesting that vedolizumab was more effective than
                            anti-TNF were significant only in the subgroup analysis comparing vedolizumab to ADA and
                            IFX. Clinical assessments (eg, use of HBI vs CDAI) were less detailed, and the study conduct
                            was less stringent than would have been the case with a randomized controlled trial.
                            Continuous endoscopic data were not available because endoscopies were carried out solely at
                            the discretion of the treating physician, making a reliable evaluation of these data
                            impossible. Observational studies are subject to selection bias and confounding, but these
                            were accounted for using a propensity score matching approach. This study included adult
                            patients only.</p>
                        </div>
                      </div>
                      <div class="column-wrap">
                        <div class="column-section text-xs text-black">* Defined as HBI score ≤ 4.<br>ADA: adalimumab;
                          CD: Crohn’s disease; CDAI: Crohn’s Disease Activity Index; HBI: Harvey–Bradshaw Index; IBD:
                          inflammatory bowel disease; IFX: infliximab; IPTW: inverse probability of treatment weighting;
                          mITT: modified intention to treat; PS: propensity score; RWE: real-world evidence; TNF: tumor
                          necrosis factor. <br>Bokemeyer B, et al. <i>Inflamm Bowel Dis</i>. 2023; doi:
                          10.1093/ibd/izad138. </div>
                      </div>
                    </div>
                  </div>
                  <div class="timeline-data" data-timeline="evolve_expansion">
                    <div class="scrollable-modal">
                      <div class="column-wrap mb-6">
                        <div class="column-section">
                          <div class="title font-bold text-xl">EVOLVE Expansion: Study design</div>
                        </div>
                      </div>
                      <div class="column-wrap mb-6">
                        <div class="column-section"><img class="mx-auto"
                            src="/entyvio_hcp/assets/images/quiz/evolve-expansion-graphic-1.svg" width="798"
                            height="332"></div>
                      </div>
                      <div class="column-wrap mb-6">
                        <div class="column-section">
                          <div class="flex flex-col items-start gap-5 md_flex-row">
                            <div class="flex flex-row items-start gap-5 w-64 mr-2"><img class="mr-2"
                                src="/entyvio_hcp/assets/images/quiz/flag-round-australia.png" width="42"
                                height="40"><img class="mr-2"
                                src="/entyvio_hcp/assets/images/quiz/flag-round-belgium.png" width="42" height="40"><img
                                class="mr-2" src="/entyvio_hcp/assets/images/quiz/flag-round-switzerland.png" width="42"
                                height="40"></div>
                            <div class="text-sm text-black">This multicenter, observational, retrospective cohort study
                              included patients who were treated at 31 sites in Australia, Belgium, and Switzerland.
                            </div>
                          </div>
                        </div>
                      </div>
                      <div class="column-wrap mb-6">
                        <div class="column-section">
                          <p class="text-sm text-black">The study evaluated the real-world clinical effectiveness and
                            safety of vedolizumab and UST as first-line biologic treatments for patients with CD.</p>
                          <p class="text-sm text-black">Inverse probability of treatment weighting was used to balance
                            demographic and clinical characteristics across treatment groups.</p>
                          <p class="text-sm text-gray-500">Limitation: This study was not a randomized controlled
                            clinical study.</p>
                        </div>
                      </div>
                      <div class="column-wrap mb-6">
                        <div class="column-section"><img class="mx-auto"
                            src="/entyvio_hcp/assets/images/quiz/evolve-expansion-graphic-4.svg" width="100%"></div>
                      </div>
                      <div class="column-wrap mb-6">
                        <div class="column-section">
                          <div class="text-sm text-black mb-2"><strong>Hierarchical algorithms for mucosal healing
                              assessment</strong></div><img class="mx-auto"
                            src="/entyvio_hcp/assets/images/quiz/evolve-expansion-graphic-3.svg" width="833"
                            height="444">
                        </div>
                      </div>
                      <div class="column-wrap">
                        <div class="column-section text-xs text-black">Study design diagram developed from information
                          presented in: Ferrante M, et al. <i>J Crohns Colitis</i>. 2023;17(Suppl 1):i768–9.<br>*
                          Time-to-event analysis was conducted using the Kaplan–Meier method.<br>Table reproduced from:
                          Ferrante M, et al. J Crohns Colitis. 2023;17(Suppl 1):i768–9.<br>CD: Crohn’s disease; GI:
                          gastrointestinal; IPW: inverse probability weighting; SAE: serious adverse event; SES-CD:
                          Simple Endoscopic Score for Crohn’s Disease; SI: serious infection; UST:
                          ustekinumab.<br>Ferrante M, et al. <i>J Crohns Colitis</i>. 2023;17(Suppl 1):i768–9. Abstract
                          P636.</div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="reference hidden">
                <div class="scrollable-ref">
                  <p>CD: Crohn’s disease; IBD: inflammatory bowel disease; TNF; tumor necrosis factor<br> 1.
                    Franchetti Y. <i>J Clin Pharmacol</i>. 2022;62:304–19. 2. Bokemeyer B, et al. <i>Inflamm Bowel
                      Dis</i>. 2023; doi: 10.1093/ibd/izad138. 3. Ferrante M, et al. <i>J Crohns Colitis</i>.
                    2023;17(Suppl 1):i768–9.</p>
                </div>
              </div>
            </div>
            <div class="trivia-modal">
              <div class="trivia-modal-overlay"></div>
              <div class="trivia-modal-wrap">
                <div class="trivia-modal-container">
                  <div class="trivia-modal-icon"><img src="undefinedassets/images/trivia_modal_icon.png"
                      alt="Trivia Icon"></div>
                  <div class="trivia-modal-close btn--modal_close close"><img
                      src="undefinedassets/images/close_icon.svg" alt="Close">
                    <div class="btn_close_circle"></div>
                  </div>
                  <div class="trivia-modal-head"></div>
                  <div class="trivia-modal-body"></div>
                  <div class="trivia-modal-footer"></div>
                </div>
              </div>
            </div>
          </div>
        </section>
      </div>
    </main>
    <footer>
      <div class="footer">
        <div class="footer-wrap">
          <div class="container">
            <div class="ref-and-abb-wrap">
              <div class="footer-arrow footer-arrow-prev mobile-only" data-arrow="prev"><img
                  src="/entyvio_hcp/assets/images/arrow_prev.png"></div>
              <div class="footer-btn"><button class="button btn hallow ref-btn" style="min-width:undefined"
                  type="button" aria-label="References & abbreviations">
                  <div class="button-wrap"><span class="btn__text">References & abbreviations</span></div>
                </button></div>
              <div class="footer-arrow footer-arrow-next mobile-only" data-arrow="next"><img
                  src="/entyvio_hcp/assets/images/arrow_next.png"></div>
            </div>
          </div>
        </div>
      </div>
    </footer>
    <div class="modal">
      <div class="modal-overlay"></div>
      <div class="modal-wrap">
        <div class="modal-container">
          <div class="modal-close btn--modal_close close"><img src="/entyvio_hcp/assets/images/close_icon.svg"
              alt="Close">
            <div class="btn_close_circle"></div>
          </div>
          <div class="modal-head"></div>
          <div class="modal-body"></div>
          <div class="modal-footer"></div>
        </div>
      </div>
    </div>
    <div id="nolandscape">
      <div class="mobile-wrap">
        <div class="phone"><svg id="Layer_2" data-name="Layer 2" xmlns="http://www.w3.org/2000/svg"
            viewBox="0 0 476.96 475.16">
            <g id="Layer_1-2" data-name="Layer 1">
              <g>
                <path
                  d="m26.41,293.71c-.5-8.49,2.78-15.4,8.72-21.34C114.57,192.95,194.11,113.63,273.3,33.97c13.11-13.19,31.45-11.84,43.17-.06,41.83,42.07,83.87,83.94,125.79,125.92,13,13.02,12.97,29.49-.17,42.65-79.51,79.58-159.16,159.02-238.5,238.76-11.05,11.1-32.38,10.95-43.14.04-32.42-32.87-65.2-65.37-97.84-98.02-8.96-8.96-17.82-18-26.9-26.84-6.44-6.28-9.8-13.67-9.31-22.72ZM294.85,55.05c-79.68,79.69-159.29,159.31-238.17,238.2,42.01,42.01,84.35,84.36,125.9,125.91,79.11-79.11,158.71-158.73,238.17-238.19-41.72-41.73-83.9-83.91-125.89-125.91Z">
                </path>
                <path
                  d="m258.46,475.16c0-9.03-.12-17.68.14-26.32.03-1.11,1.9-2.96,3.1-3.12,37.74-4.87,70.8-20.66,101.08-42.99,21.99-16.22,41-35.31,55.51-58.59,3.38-5.41,6.01-11.28,8.99-16.95-8.61-9.06-17.09-17.99-25.38-26.72,24.71-24.76,49.37-49.46,73.93-74.06,11.8,99.5-69.23,236.77-217.37,248.75Z">
                </path>
                <path
                  d="m218.51,0c0,8.96-.05,17.44.03,25.93.02,2.46-.75,3.37-3.38,3.7-46.26,5.72-86.6,24.02-120.63,56.24-18.93,17.92-33.93,38.42-44.76,62.13,8.55,9.04,17.02,17.98,25.19,26.62-24.73,24.73-49.41,49.42-73.89,73.9C-10.5,146.96,72.23,11.62,218.51,0Z">
                </path>
              </g>
            </g>
          </svg></div>
        <div class="message">
          <p class="text-center leading-7">Please rotate your device for an<br>optimized user experience</p>
        </div>
      </div>
    </div>
    <script src="/entyvio_hcp/assets/scripts/main.js"></script>
  </body>
</html>
